A detailed history of Tap Consulting, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Tap Consulting, LLC holds 4,871 shares of JNJ stock, worth $743,509. This represents 0.16% of its overall portfolio holdings.

Number of Shares
4,871
Previous 4,838 0.68%
Holding current value
$743,509
Previous $707,000 11.6%
% of portfolio
0.16%
Previous 0.16%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$145.48 - $167.38 $4,800 - $5,523
33 Added 0.68%
4,871 $789,000
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $9,962 - $10,886
69 Added 1.45%
4,838 $707,000
Q1 2024

Apr 22, 2024

SELL
$155.22 - $162.74 $2,173 - $2,278
-14 Reduced 0.29%
4,769 $754,000
Q4 2023

Feb 02, 2024

SELL
$145.6 - $158.88 $4,804 - $5,243
-33 Reduced 0.69%
4,783 $749,000
Q3 2023

Dec 05, 2023

SELL
$155.75 - $174.48 $324,894 - $363,965
-2,086 Reduced 30.22%
4,816 $750,000
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $33,030 - $35,547
-214 Reduced 3.01%
6,902 $1.14 Million
Q1 2023

Apr 18, 2023

SELL
$151.05 - $180.26 $83,530 - $99,683
-553 Reduced 7.21%
7,116 $1.1 Million
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $5,767 - $6,472
36 Added 0.47%
7,669 $0
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $21,618 - $24,055
134 Added 1.79%
7,633 $1.25 Million
Q2 2022

Jul 26, 2022

SELL
$168.19 - $186.01 $36,329 - $40,178
-216 Reduced 2.8%
7,499 $1.33 Million
Q1 2022

Apr 26, 2022

BUY
$158.14 - $179.59 $5,693 - $6,465
36 Added 0.47%
7,715 $1.37 Million
Q4 2021

Jan 27, 2022

BUY
$155.93 - $173.01 $5,613 - $6,228
36 Added 0.47%
7,679 $1.31 Million
Q3 2021

Nov 03, 2021

BUY
$161.5 - $179.47 $3,553 - $3,948
22 Added 0.29%
7,643 $1.23 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $2,392 - $2,566
15 Added 0.2%
7,621 $1.26 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $765 - $852
5 Added 0.07%
7,606 $1.25 Million
Q4 2020

Jan 19, 2021

BUY
$137.11 - $157.38 $27,559 - $31,633
201 Added 2.72%
7,601 $1.2 Million
Q3 2020

Oct 20, 2020

BUY
$140.38 - $153.83 $1,263 - $1,384
9 Added 0.12%
7,400 $1.1 Million
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $139,630 - $168,572
-1,084 Reduced 12.79%
7,391 $1.04 Million
Q1 2020

Apr 29, 2020

BUY
$111.14 - $153.99 $12,892 - $17,862
116 Added 1.39%
8,475 $1.11 Million
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $20,782 - $23,869
163 Added 1.99%
8,359 $1.22 Million
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $64,109 - $71,780
-505 Reduced 5.8%
8,196 $1.06 Million
Q1 2019

May 03, 2019

BUY
$125.72 - $139.79 $1.09 Million - $1.22 Million
8,701 New
8,701 $1.22 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $399B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Tap Consulting, LLC Portfolio

Follow Tap Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.